Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 638413, 11 pages
http://dx.doi.org/10.1155/2010/638413
Review Article

Biomarkers for Lupus Nephritis: A Critical Appraisal

Department of Medicine & Geriatrics, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases, Pok Oi Hospital, Hong Kong

Received 5 January 2010; Accepted 22 March 2010

Academic Editor: Charles Via

Copyright © 2010 Chi Chiu Mok. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [92 citations]

The following is the list of published articles that have cited the current article.

  • Boglárka Brúgós, and Margit Zeher, “Biomarkers in lupus nephritis,” Orvosi Hetilap, vol. 151, no. 29, pp. 1171–1176, 2010. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, Ling Yin Ho, Hoi Wah Leung, and Lap Gate Wong, “Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus,” Translational Research, vol. 156, no. 6, pp. 320–325, 2010. View at Publisher · View at Google Scholar
  • A. El-Hewala, Ghada S. Nageeb, Eman E. El-shahawy, Doaa M. Sharaf, Alaa A. Omran, Fawzy A.F. El-Messallamy, and Shereen Eassa, “Anti-C1q and anti-dsDNA antibodies in systemic lupus erythematosus: Relationship with disease activity and renal involvement in Sharkia governorate, Egypt,” The Egyptian Rheumatologist, vol. 33, no. 4, pp. 203–208, 2011. View at Publisher · View at Google Scholar
  • Amal El-shehaby, Hanan Darweesh, Mohamed El-Khatib, Mohamed Momtaz, Samar Marzouk, Nashwa El-Shaarawy, and Yasser Emad, “Correlations of Urinary Biomarkers, TNF-Like Weak Inducer of Apoptosis (TWEAK), Osteoprotegerin (OPG), Monocyte Chemoattractant Protein-1 (MCP-1), and IL-8 with Lupus Nephritis,” Journal Of Clinical Immunology, vol. 31, no. 5, pp. 848–856, 2011. View at Publisher · View at Google Scholar
  • Ronald Herbst, Zheng Liu, Bahija Jallal, and Yihong Yao, “Biomarkers for systemic lupus erythematosus,” International Journal of Rheumatic Diseases, vol. 15, no. 5, pp. 433–444, 2012. View at Publisher · View at Google Scholar
  • Zheng Liu, and Anne Davidson, “Taming lupus—a new understanding of pathogenesis is leading to clinical advances,” Nature Medicine, vol. 18, no. 6, pp. 871–882, 2012. View at Publisher · View at Google Scholar
  • S. Anna Sargsyan, and Joshua M. Thurman, “Molecular Imaging of Autoimmune Diseases and Inflammation,” Molecular Imaging, vol. 11, no. 3, pp. 251–264, 2012. View at Publisher · View at Google Scholar
  • C. P. Lin, I. Adrianto, C. J. Lessard, J. A. Kelly, K. M. Kaufman, J. M. Guthridge, B. I. Freedman, J-M Anaya, M. E. Alarcon-Riquelme, B. A. Pons-Estel, J. Martin, S. Glenn, A. Adler, S-C Bae, S-Y Park, S-Y Bang, Y-W Song, S. A. Boackle, E. E. Brown, J. C. Edberg, G. S. Alarcon, M. A. Petri, L. A. Criswell, R. Ramsey-Goldman, J. D. Reveille, L. M. Vila, G. S. Gilkeson, D. L. Kamen, J. Ziegler, C. O. Jacob, A. Rasmussen, J. A. James, R. P. Kimberly, J. T. Merrill, T. B. Niewold, R. H. Scofield, A. M. Stevens, B. P. Tsao, T. J. Vyse, C. D. Langefeld, K. L. Moser, J. B. Harley, P. M. Gaffney, and C. G. Montgomery, “Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis,” Genes And Immunity, vol. 13, no. 3, pp. 232–238, 2012. View at Publisher · View at Google Scholar
  • Joseph M. Ahearn, Chau-Ching Liu, Amy H. Kao, and Susan Manzi, “Biomarkers for systemic lupus erythematosus,” Translational Research, vol. 159, no. 4, pp. 326–342, 2012. View at Publisher · View at Google Scholar
  • G. Ruiz-Irastorza, G. Espinosa, M.A. Frutos, J. Jiménez Alonso, M. Praga, L. Pallarés, F. Rivera, Á. Robles Marhuenda, A. Segarra, and C. Quereda, “Diagnóstico y tratamiento de la nefritis lúpica,” Revista Clínica Española, vol. 212, no. 3, pp. 147.e1–147.e30, 2012. View at Publisher · View at Google Scholar
  • Prapaporn Pisitkun, Hye-Lin Ha, Hongshan Wang, Estefania Claudio, Caitlyn C. Tivy, Hua Zhou, Tanya N. Mayadas, Gabor G. Illei, and Ulrich Siebenlist, “Interleukin-17 Cytokines Are Critical in Development of Fatal Lupus Glomerulonephritis,” Immunity, vol. 37, no. 6, pp. 1104–1115, 2012. View at Publisher · View at Google Scholar
  • Todd J. Stanhope, Wendy M. White, Kevin G. Moder, Andrew Smyth, and Vesna D. Garovic, “Obstetric Nephrology: Lupus and Lupus Nephritis in Pregnancy,” Clinical Journal of The American Society of Nephrology, vol. 7, no. 12, pp. 2089–2099, 2012. View at Publisher · View at Google Scholar
  • Julia Barbado, Debora Martin, Luisa Vega, Raquel Almansa, Lisbeth Goncalves, Mercedes Nocito, Antonio Jimeno, Raul Ortiz de Lejarazu, and Jesus F. Bermejo-Martin, “MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus,” Cytokine, vol. 60, no. 2, pp. 583–586, 2012. View at Publisher · View at Google Scholar
  • D. Hashad, M. H. Abdelmagid, and S. H. Elsherif, “microRNA146a Expression in Lupus Patients With and Without Renal Complications,” Journal Of Clinical Laboratory Analysis, vol. 26, no. 1, pp. 35–40, 2012. View at Publisher · View at Google Scholar
  • Izeta Aganovic-Musinovic, Jasenko Karamehic, Lamija Zecevic, Faris Gavrankapetanovic, Nesina Avdagic, Asija Zaciragic, Tomislav Jukic, Nerima Grcic, and Suvada Svrakic, “Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes,” Autoimmune Diseases, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • Alberto de Zubiria Salgado, and Catalina Herrera-Diaz, “Lupus Nephritis: An Overview of Recent Findings,” Autoimmune Diseases, vol. 2012, pp. 1–21, 2012. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, “Understanding lupus nephritis: diagnosis, management, and treatment options.,” International journal of women's health, vol. 4, pp. 213–22, 2012. View at Publisher · View at Google Scholar
  • Guillermo Ruiz-Irastorza, Gerard Espinosa, Miguel A. Frutos, Juan Jiménez-Alonso, Manuel Praga, Lucio Pallarés, Francisco Rivera, Ángel Robles-Marhuenda, Alfons Segarra, and Carlos Quereda, “Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.),” Nefrologia, vol. 32, no. 1, pp. 1–45, 2012. View at Publisher · View at Google Scholar
  • R. Aggarwal, “Urinary free light chains: a potential biomarker in lupus nephritis,” Rheumatology, 2013. View at Publisher · View at Google Scholar
  • Xi Chen, Zhenke Wen, Wei Xu, and Sidong Xiong, “Granulin Exacerbates Lupus Nephritis via Enhancing Macrophage M2b Polarization,” PLoS ONE, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Hualin Ma, Xianggui Zhang, Xinzhou Zhang, Dan Yang, Lingguo Meng, Yi Zhang, and Shuyan Zhou, “The effect of esculentoside A on lupus nephritis-prone BXSB mice,” Archives of Medical Science, vol. 9, no. 2, pp. 354–360, 2013. View at Publisher · View at Google Scholar
  • M. Hanaoka, T. Gono, Y. Kawaguchi, K. Uchida, Y. Koseki, Y. Katsumata, H. Kaneko, K. Takagi, H. Ichida, K. Nitta, and H. Yamanaka, “Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis,” Rheumatology, 2013. View at Publisher · View at Google Scholar
  • Adeel Zubair, “Lupus Nephritis: Review of the Literature,” Current Allergy and Asthma Reports, vol. 13, no. 6, pp. 580–586, 2013. View at Publisher · View at Google Scholar
  • Maaz A. Abbasi, and Leah A. Haseleypp. 561–575, 2013. View at Publisher · View at Google Scholar
  • Chau-Ching Liu, Amy H. Kao, Susan Manzi, and Joseph M. Ahearn, “Biomarkers in systemic lupus erythematosus: Challenges and prospects for the future,” Therapeutic Advances in Musculoskeletal Disease, vol. 5, no. 4, pp. 210–233, 2013. View at Publisher · View at Google Scholar
  • Elisabeth Binder, and Monika Edelbauer, “Use of Biomarkers in the Management of Children with Lupus,” Current Rheumatology Reports, vol. 15, no. 3, 2013. View at Publisher · View at Google Scholar
  • Anne Davidson, Celine Berthier, and Matthias Kretzler, “Pathogenetic Mechanisms in Lupus Nephritis,” Dubois' Lupus Erythematosus and Related Syndromes, pp. 237–255, 2013. View at Publisher · View at Google Scholar
  • Ramalingam Bethunaickan, Celine C. Berthier, Weijia Zhang, Ridvan Eksi, Hong-Dong Li, Yuanfang Guan, Matthias Kretzler, and Anne Davidson, “Identification of Stage-Specific Genes Associated With Lupus Nephritis and Response to Remission Induction in (NZB × NZW)F1 and NZM2410 Mice,” Arthritis & Rheumatology, vol. 66, no. 8, pp. 2246–2258, 2014. View at Publisher · View at Google Scholar
  • Valentina Zivkovic, Aleksandra Stankovic, Tatjana Cvetkovic, Branka Mitic, Svetislav Kostic, Jovan Nedovic, and Bojana Stamenkovic, “Anti-dsDNA, Anti-Nucleosome and Anti-C1q Antibodies as Disease Activity Markers in Patients with Systemic Lupus Erythematosus,” Srpski Arhiv Za Celokupno Lekarstvo, vol. 142, no. 7-8, pp. 431–436, 2014. View at Publisher · View at Google Scholar
  • B. Brugos, L. Sebestyen, T. Tarr, and Z. Vincze, “Use of cyclophosphamide and other immunosuppressive drugs in the treatment of patients with lupus nephritis,” Pharmazie, vol. 69, no. 6, pp. 442–444, 2014. View at Publisher · View at Google Scholar
  • Desmond Y. H. Yap, and Tak Mao Chan, “Treatment of lupus nephritis: practical issues in Asian countries,” International Journal of Rheumatic Diseases, 2014. View at Publisher · View at Google Scholar
  • Claudia Mora, Ana Milena Arbeláez, Jorge Enrique Medina, Ana Isabel Ospina, Consuelo Romero Sánchez, Paula Andrea Valencia Toro, Diego Alejandro Jaimes, Rafael Valle Oñate, Santos G. Ana María, and John Londoño, “El papel de los anticuerpos anti-cromatina, antiC1q y las fracciones del complemento unidas a células en el diagnóstico precoz de actividad lúpica,” Revista Colombiana de Reumatología, vol. 21, no. 2, pp. 76–83, 2014. View at Publisher · View at Google Scholar
  • Abdulkareem Omer Alsuwaida, “The clinical significance of serial kidney biopsies in lupus nephritis,” Modern Rheumatology, vol. 24, no. 3, pp. 453–456, 2014. View at Publisher · View at Google Scholar
  • M. T. Torres-Salido, J. Cortes-Hernandez, X. Vidal, A. Pedrosa, M. Vilardell-Tarres, and J. Ordi-Ros, “Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis,” Nephrology Dialysis Transplantation, 2014. View at Publisher · View at Google Scholar
  • Malak Nabil, Manar Raafat, Sameh AbouZeid, and Azza S. Hassanein, “Anti-C1q antibodies in lupus nephritis: Detection and relationship with disease activity,” Life Science Journal, vol. 11, no. 12, pp. 940–946, 2014. View at Publisher · View at Google Scholar
  • Hani Susianti, Kusworini Handono, Atma Gunawan, Karyono Mintaroem, Basuki B. Purnomo, and Handono Kalim, “Transforming growth factor β1 is better than α smooth muscle actin for the prediction of renal fibrosis in patients with nephritic lupus,” Biomarkers and Genomic Medicine, 2014. View at Publisher · View at Google Scholar
  • Fabrizio Conti, Fulvia Ceccarelli, Antonietta Gigante, Biagio Barbano, Carlo Perricone, Laura Massaro, Francesco Martinelli, Francesca Romana Spinelli, Kostantinos Giannakakis, Guido Valesini, and Rosario Cianci, “Ultrasonographic Evaluation Of Renal Resistive Index In Patients With Lupus Nephritis: Correlation With Histologic Findings,” Ultrasound in Medicine and Biology, vol. 40, no. 11, pp. 2573–2580, 2014. View at Publisher · View at Google Scholar
  • Samah A. El Bakry, Amina Bader El Din, Al Hussein M. El Dakrony, Nouran M. Abaza, Rania A. Abo-Shady, Nesrine A. Mohamed, and Ola H. Nada, “Anti-nucleosome antibodies: A potential surrogate marker for renal affection in lupus patients with insignificant proteinuria,” The Egyptian Rheumatologist, 2014. View at Publisher · View at Google Scholar
  • Philipp Enghard, Karlfried Aupperle, Jens Y. Humrich, Falk Hiepe, Marina Backhaus, Radbruch, Gerd R. Burmester, Gabriela Riemekasten, Claudia Rieder, Katharina Kopetschke, Klocke, Reinmar Undeutsch, Robert Biesen, Duska Dragun, Maik Gollasch, and Udo Schneider, “Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 277–283, 2014. View at Publisher · View at Google Scholar
  • Tereza Brito, Maria Vilar, José Almeida, Ana Faria, Sarah Medeiros, Maria Medeiros, Edna Silva, Vanessa Silva, Luanda Souza, Luisa Arruda, Tatiana Costa, Geraldo Junior, Antonio G Oliveira, and Valéria Sales, “Measuring eosinophiluria, urinary eosinophil cationic protein and urinary interleukin-5 in patients with Lupus Nephritis,” Allergy, Asthma & Clinical Immunology, vol. 10, no. 1, pp. 61, 2014. View at Publisher · View at Google Scholar
  • Linn Petersson, Linda Dexlin-Mellby, Anders A. Bengtsson, Gunnar Sturfelt, Carl A. K. Borrebaeck, and Christer Wingren, “Multiplexing of miniaturized planar antibody arrays for serum protein profiling – a biomarker discovery in SLE nephritis,” Lab on a Chip, vol. 14, no. 11, pp. 1931, 2014. View at Publisher · View at Google Scholar
  • Hani Susianti, Atma Gunawan, Jayarani Fatimah Putri, Basuki B Purnomo, Kusworini Handono, and Handono Kalim, “The Potential effect of G915C polymorphism in regulating TGF-β1 transport into Endoplasmic Reticulum for cytokine production.,” Bioinformation, vol. 10, no. 8, pp. 487–90, 2014. View at Publisher · View at Google Scholar
  • Zhigang Liu, Andrew Ofosu, Richard Williams, and Navdeep Grewal, “Acute renal failure secondary to lupus nephritis confirmed by renal biopsy with an unusually normal immunological profile,” Case Reports in Clinical Medicine, vol. 03, no. 01, pp. 6–9, 2014. View at Publisher · View at Google Scholar
  • Anne Davidson, Ramalingam Bethunaickan, Celine Berthier, Ranjit Sahu, Weijia Zhang, and Matthias Kretzler, “Molecular studies of lupus nephritis kidneys,” Immunologic Research, 2015. View at Publisher · View at Google Scholar
  • Sachiko Onishi, Endy Adnan, Jun Ishizaki, Tatsuhiko Miyazaki, Yuki Tanaka, Takuya Matsumoto, Koichiro Suemori, Masachika Shudou, Takafumi Okura, Hiroyuki Takeda, Tatsuya Sawasaki, Masaki Yasukawa, and Hitoshi Hasegawa, “Novel Autoantigens Associated with Lupus Nephritis,” Plos One, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • Alvaro Orjuela, Adisak Suwanichkul, Debra Canter, Charles G. Minard, Sridevi Devaraj, M. John Hicks, Eyal Muscal, and Scott E. Wenderfer, “High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus,” American Journal of Nephrology, vol. 41, no. 3, pp. 241–247, 2015. View at Publisher · View at Google Scholar
  • Ramnath Misra, and Ranjan Gupta, “Biomarkers in lupus nephritis,” International Journal of Rheumatic Diseases, vol. 18, no. 2, pp. 219–232, 2015. View at Publisher · View at Google Scholar
  • Agneta Zickert, Petra Amoudruz, Yvonne Sundstrom, Johan Ronnelid, Vivianne Malmstrom, and Iva Gunnarsson, “IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment,” Bmc Immunology, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Julia Menke, Kerstin Amann, Lorenzo Cavagna, Maria Blettner, Arndt Weinmann, Andreas Schwarting, and Vicki R. Kelley, “Colony-Stimulating Factor-1: A Potential Biomarker for Lupus Nephritis,” Journal Of The American Society Of Nephrology, vol. 26, no. 2, pp. 379–389, 2015. View at Publisher · View at Google Scholar
  • Ivana Stiborová, Vlastimil Král, Jozef Rovenský, and Stanislava Blažíčková, “Clinical significance of anti-C1q antibodies in SLE,” Acta Facultatis Pharmaceuticae Universitatis Comenianae, vol. 62, no. s11, 2015. View at Publisher · View at Google Scholar
  • Hani Susianti, Vincentia M. Iriane, Suriya Dharmanata, Kusworini Handono, Anik Widijanti, Atma Gunawan, and Handono Kalim, “Analysis of urinary TGF-β1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis,” Pathophysiology, 2015. View at Publisher · View at Google Scholar
  • Ajit Sadana, and Neeti Sadana, “Binding and Dissociation of Biomarkers for Systemic Lupus Erythematosus,” Biomarkers and Biosensors, pp. 271–376, 2015. View at Publisher · View at Google Scholar
  • Mudan Lu, Shanshan Yu, Wei Xu, Bo Gao, and Sidong Xiong, “HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response,” Journal of Immunology Research, vol. 2015, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  • Samah Abdel Rahman El Bakry, AbdelAzim Mohamed Alhefny, Dina Shawky Al-Zifzaf, Ola Hasan Nada, Rania Hamdy El Kabarity, and Khaled Omar, “Interleukin-18 as a Biomarker of Subclinical Lupus Nephritis,” Archives Of Rheumatology, vol. 30, no. 1, pp. 6–15, 2015. View at Publisher · View at Google Scholar
  • Song-Chou Hsieh, Chang-Youh Tsai, and Chia-Li Yu, “Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems,” Open Access Rheumatology: Research and Reviews, vol. 8, pp. 81–91, 2016. View at Publisher · View at Google Scholar
  • M. N. Salem, H. A. Taha, M. Abd El-Fattah El-Feqi, N. N. Eesa, and R. A. Mohamed, “Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis,” Zeitschrift für Rheumatologie, 2016. View at Publisher · View at Google Scholar
  • Samar Soliman, and Chandra Mohan, “Lupus Nephritis Biomarkers,” Clinical Immunology, 2016. View at Publisher · View at Google Scholar
  • Celine C. Berthier, Matthias Kretzler, and Anne Davidson, “A systems approach to renal inflammation in SLE,” Clinical Immunology, 2016. View at Publisher · View at Google Scholar
  • Diego A. González-Sánchez, Cristian M. Álvarez, Gloria Vásquez, and José A. Gómez-Puerta, “Papel de la vía de señalización del TWEAK/Fn14 en la nefritis lúpica y otros escenarios clínicos,” Nefrología, 2016. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, Hui Hua Ding, Marwa Kharboutli, and Chandra Mohan, “Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus,” Arthritis Care & Research, 2016. View at Publisher · View at Google Scholar
  • Y. H. Lee, and G. G. Song, “Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis,” Zeitschrift für Rheumatologie, 2016. View at Publisher · View at Google Scholar
  • Jiabin Wu, Lixin Wei, Weiming Wang, Xianghui Zhang, Li Chen, and Changda Lin, “Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity,” Rheumatology International, vol. 36, no. 6, pp. 759–767, 2016. View at Publisher · View at Google Scholar
  • Ahmed El-Gohary, Ann Hegazy, Mostafa Abbas, Noha Kamel, and Samah Ismail Nasef, “Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis,” Journal of Clinical Laboratory Analysis, 2016. View at Publisher · View at Google Scholar
  • Hawra'a Adnan Mohammed, and Falah Salim Manhal, “Relationship between anti-ds-DNA antibodies and abnormal kidney function tests in patients with lupus nephritis,” American Journal of Immunology, vol. 12, no. 2, pp. 37–42, 2016. View at Publisher · View at Google Scholar
  • Rawhya R. El-Shereef, Heba Tawfik, Emad A. Abdel-Naeam, and Ahmed Lotfi, “Serum and urinary interleukin-6 in assessment of renal activity in egyptian patients with systemic lupus erythematosus,” Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, vol. 9, pp. 29–36, 2016. View at Publisher · View at Google Scholar
  • Shohda A. El-Maraghy, Tarek K. Motawi, Dahlia A. Mohsen, and Mona A. Kortam, “MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus,” Chemico-Biological Interactions, vol. 260, pp. 110–116, 2016. View at Publisher · View at Google Scholar
  • R Ma, W Jiang, Z Li, Y Sun, and Z Wei, “Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients,” Lupus, vol. 25, no. 14, pp. 1577–1586, 2016. View at Publisher · View at Google Scholar
  • Elkin Navarro-Quiroz, Eduardo Egea, Lisandro Pacheco-Lugo, Hernan Lorenzi, Yirys Díaz-Olmos, Lisneth Almendrales, Edwin Rico, Antonio Iglesias, Gustavo Aroca, Roberto Navarro, and Pierine España-Puccini, “High-throughput sequencing reveals circulating miRNAs as potential biomarkers of kidney damage in patients with systemic lupus erythematosus,” PLoS ONE, vol. 11, no. 11, 2016. View at Publisher · View at Google Scholar
  • Reinhard Voll, Martin Herrmann, Jürgen Dieker, Johan Der Van Vlag, Jo H. Berden, Marinka Bakker, Jean-Paul Briand, Sylviane Muller, Christopher Sjöwall, and Luuk B. Hilbrands, “Autoantibodies against modified histone peptides in sle patients are associated with disease activity and lupus nephritis,” PLoS ONE, vol. 11, no. 10, 2016. View at Publisher · View at Google Scholar
  • Anupam Guleria, Chunni Lal Khetrapal, Durgesh Dubey, Smriti Chaurasia, Sajal Ajmani, Umesh Kumar, Paul Bacon, Ramnath Misra, Dinesh Kumar, Avadhesh Pratap, Atul Rawat, Edavalath Sukesh, and Sanat Phatak, “NMR based serum metabolomics reveals a distinctive signature in patients with Lupus Nephritis,” Scientific Reports, vol. 6, 2016. View at Publisher · View at Google Scholar
  • C. C. Mok, “Towards new avenues in the management of lupus glomerulonephritis,” Nature Reviews Rheumatology, 2016. View at Publisher · View at Google Scholar
  • H. Ding, M. Kharboutli, R. Saxena, and T. Wu, “Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis,” Clinical & Experimental Immunology, vol. 184, no. 1, pp. 11–18, 2016. View at Publisher · View at Google Scholar
  • Philipp Enghard, Anna-Sophie Grießbach, Valerie Langhans, Jens Y. Humrich, Robert Biesen, Duska Dragun, Gerd-Rüdiger Burmester, Jan Klocke, Gabriela Riemekasten, Katharina Kopetschke, and Andreas Radbruch, “Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages,” European Journal of Immunology, vol. 47, no. 1, pp. 180–192, 2016. View at Publisher · View at Google Scholar
  • Wan Syamimee Wan Ghazali, Rahimah Iberahim, and Noor Suryani Mohd Ashari, “Serum vascular endothelial growth factor (VEGF) as a biomarker for disease activity in lupus nephritis,” Malaysian Journal of Medical Sciences, vol. 24, no. 5, pp. 62–72, 2017. View at Publisher · View at Google Scholar
  • Jacek Rysz, Anna Gluba-Brzózka, Beata Franczyk, Zbigniew Jabłonowski, and Aleksandra Ciałkowska-Rysz, “Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome,” International Journal of Molecular Sciences, vol. 18, no. 8, pp. 1702, 2017. View at Publisher · View at Google Scholar
  • Diego A. González-Sánchez, Cristian M. Álvarez, Gloria Vásquez, and José Alfredo Gómez-Puerta, “Role of TWEAK/Fn14 signalling pathway in lupus nephritis and other clinical settings,” Nefrología (English Edition), 2017. View at Publisher · View at Google Scholar
  • James J. Paparello, “Diagnostic Testing in Glomerular Disease,” Glomerulonephritis, pp. 1–12, 2017. View at Publisher · View at Google Scholar
  • P Delfani, G Sturfelt, B Gullstrand, A Carlsson, M Kassandra, C A K Borrebaeck, A A Bengtsson, and C Wingren, “Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity,” Lupus, vol. 26, no. 4, pp. 373–387, 2017. View at Publisher · View at Google Scholar
  • Di Song, Wei-yi Guo, Feng-mei Wang, Yong-zhe Li, Yan Song, Feng Yu, and Ming-hui Zhao, “Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis,” The American Journal of the Medical Sciences, vol. 353, no. 3, pp. 247–257, 2017. View at Publisher · View at Google Scholar
  • Fang Li, Shupeng Wu, and Jing Wang, “Dysregulation of miRNA-146a contributes to the development of lupus nephritis via targeting of TRAF6,” Personalized Medicine, vol. 14, no. 2, pp. 131–139, 2017. View at Publisher · View at Google Scholar
  • Jin Ding, Zhaohui Zheng, Xueyi Li, Yuan Feng, Nan Leng, Zhenbiao Wu, and Ping Zhu, “Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria,” Medical Science Monitor, vol. 23, pp. 631–639, 2017. View at Publisher · View at Google Scholar
  • Valentina Živković, Tatjana Cvetković, Branka Mitić, Bojana Stamenković, Sonja Stojanović, Biljana Radovanović-Dinić, and Vladimir Jurišić, “Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study,” Rheumatology International, 2017. View at Publisher · View at Google Scholar
  • Ricong Xu, Zhijian Li, Na Zhou, Peiran Yin, Yue Li, Xueqing Tang, Tian Wu, Zhong Zhong, Yan Wang, Zhen Ai, Ou Wang, Qibin Li, Nan Chen, Xiaoqin Yang, Junbin Fang, Ping Fu, Jieruo Gu, Kun Ye, Jian Chen, Lie Dai, Huafeng Liu, Zhangsuo Liu, Rongjun Liu, Yunhua Liao, Jianxin Wan, Guohua Ding, Jinghong Zhao, Hao Zhang, Shuxia Fu, Liangdan Sun, Xuejun Zhang, Huanming Yang, Jian Wang, Juan Shen, Jun Wang, Jianjun Liu, Yingrui Li, Xueqing Yu, Ming Li, Minghui Zhao, Meng Wang, Qijun Liao, and Haiping Mao, “Association Analysis of the MHC in Lupus Nephritis.,” Journal of the American Society of Nephrology : JASN, vol. 28, no. 11, pp. 3383–3394, 2017. View at Publisher · View at Google Scholar
  • Hani Susianti, Jullyanny W. Wijaya, Ati Rastini, Kusworini Handono, Atma Gunawan, and Handono Kalim, “Urinary Neutrophil Gelatinase-Associated Lipocalin to Monitor Lupus Nephritis Disease Activity,” Biomarker Insights, vol. 10, pp. BMI.S27625, 2017. View at Publisher · View at Google Scholar
  • J A Gómez-Puerta, B Ortiz-Reyes, T Urrego, A L Vanegas-García, C H Muñoz, L A González, R Cervera, and G Vásquez, “Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients,” Lupus, pp. 096120331773822, 2017. View at Publisher · View at Google Scholar
  • Samar Soliman, Fatma A. Mohamed, Faten M. Ismail, Samantha Stanley, Ramesh Saxena, and Chandra Mohan, “Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis,” International Journal of Rheumatic Diseases, 2017. View at Publisher · View at Google Scholar
  • A. Koutsonikoli, M. Trachana, E. Farmaki, V. Tzimouli, P. Pratsidou-Gertsi, N. Printza, A. Garyphallos, V. Galanopoulou, F. Kanakoudi-Tsakalidou, and F. Papachristou, “Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis,” Clinical & Experimental Immunology, vol. 188, no. 1, pp. 79–85, 2017. View at Publisher · View at Google Scholar
  • Young Ho Lee, and Gwan Gyu Song, “Urinary Tumor Necrosis Factor-like Weak Inducer of Apoptosis as a Biomarker for Lupus Nephritis: A Meta-analysis,” Journal of Rheumatic Diseases, vol. 24, no. 2, pp. 85, 2017. View at Publisher · View at Google Scholar
  • Anupam Guleria, Sanat Phatak, Durgesh Dubey, Sandeep Kumar, abhishek zanwar, Smriti Chaurasia, Umesh Kumar, Ranjan Gupta, Amita Aggarwal, Dinesh Kumar, and Ramnath Misra, “NMR based serum metabolomics reveals reprogramming of lipid dysregulation following Cyclophosphamide based induction therapy in lupus nephritis .,” Journal of Proteome Research, 2018. View at Publisher · View at Google Scholar
  • Eckart Mummert, Marvin J. Fritzler, Christopher Sjöwall, Chelsea Bentow, and Michael Mahler, “The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination,” Journal of Immunological Methods, 2018. View at Publisher · View at Google Scholar
  • Mohamed S. El Shahawy, Mahmoud H. Hemida, Hafez A. Abdel-Hafez, Tarek Z. El-Baz, Abdel-Wahab M. Lotfy, and Tarek M. Emran, “Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis,” Scandinavian Journal of Clinical and Laboratory Investigation, pp. 1–5, 2018. View at Publisher · View at Google Scholar
  • Chi Chiu Mok, Faten Ismail Mohamed, Samar Soliman, Chandra Mohan, Ling Yin Ho, and Fatma A. Mohamed, “Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis,” Arthritis Research and Therapy, vol. 20, no. 1, 2018. View at Publisher · View at Google Scholar